CD163 and prostate cancer: IHC analysis of tissue specimens derived from 93 Italian prostate cancer patients has identified that high amount of CD163+ TAMs was associated with extracapsular extension (Gleason score > 7) and worse biochemical recurrence-free survival rates (257).